NCT01562405 2026-01-14Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaMassachusetts General HospitalPhase 1 Active not recruiting33 enrolled
NCT02230917 2016-09-01A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple MyelomaIndiana UniversityPhase 2 Withdrawn